Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders

Research output: Contribution to journalArticlepeer-review

Abstract

The development and clinical implementation of personalized medicine crucially depends on the availability of high-quality human biosamples; animal models, although capable of modeling complex human diseases, cannot reflect the large variation in the human genome, epigenome, transcriptome, proteome, and metabolome. Although the biosamples available from public biobanks that store human tissues and cells may represent the large human diversity for most diseases, these samples are not always sufficient for developing biomarkers for patient-tailored therapies for neuropsychiatric disorders. Postmortem human tissues are available from many biobanks; nevertheless, collections of neuronal human cells from large patient cohorts representing the human diversity remain scarce. Two tools are gaining popularity for personalized medicine research on neuropsychiatric disorders: human induced pluripotent stem cell-derived neurons and human lymphoblastoid cell lines. This review examines and contrasts the advantages and limitations of each tool for personalized medicine research.

Original languageEnglish
Pages (from-to)267-276
Number of pages10
JournalDialogues in Clinical Neuroscience
Volume18
Issue number3
StatePublished - 2016

Keywords

  • Biobank
  • IPSC-derived neuron
  • Lymphoblastoid cell line
  • Neuropsychiatric disorder
  • Personalized therapy biomarker

Fingerprint

Dive into the research topics of 'Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders'. Together they form a unique fingerprint.

Cite this